CINECA IRIS Institutional Research Information System

DOGLIOTTI, Luigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.042
EU - Europa 5.601
AS - Asia 2.663
AF - Africa 51
OC - Oceania 37
SA - Sud America 32
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.431
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.823
CN - Cina 1.689
SE - Svezia 839
DE - Germania 817
IE - Irlanda 734
UA - Ucraina 685
FR - Francia 591
IT - Italia 566
FI - Finlandia 477
KR - Corea 432
GB - Regno Unito 391
SG - Singapore 251
CA - Canada 208
PL - Polonia 181
AT - Austria 137
VN - Vietnam 120
IN - India 48
DK - Danimarca 42
AU - Australia 33
BE - Belgio 29
JP - Giappone 29
NL - Olanda 29
CZ - Repubblica Ceca 28
SN - Senegal 25
TW - Taiwan 23
BR - Brasile 16
EG - Egitto 15
TR - Turchia 14
RU - Federazione Russa 13
HK - Hong Kong 11
IR - Iran 11
MX - Messico 9
TH - Thailandia 8
ES - Italia 7
CH - Svizzera 6
PK - Pakistan 6
AR - Argentina 5
CL - Cile 5
LB - Libano 5
MU - Mauritius 5
NO - Norvegia 5
PH - Filippine 5
ZA - Sudafrica 5
BG - Bulgaria 4
EU - Europa 4
NZ - Nuova Zelanda 4
PE - Perù 4
GR - Grecia 3
MK - Macedonia 3
RS - Serbia 3
EC - Ecuador 2
HR - Croazia 2
ID - Indonesia 2
JO - Giordania 2
MM - Myanmar 2
PT - Portogallo 2
RO - Romania 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BY - Bielorussia 1
CU - Cuba 1
CY - Cipro 1
DZ - Algeria 1
LT - Lituania 1
LV - Lettonia 1
NI - Nicaragua 1
SI - Slovenia 1
Totale 14.431
Salva come PNG Salva come JPEG
Città #
Beijing 1.315
Chandler 809
Dublin 690
Houston 611
Ann Arbor 445
Jacksonville 397
Villeurbanne 378
Princeton 260
Medford 240
Dearborn 175
Warsaw 174
Fairfield 159
Nyköping 144
Wilmington 142
Milan 140
Vienna 135
Ashburn 134
Singapore 132
Toronto 132
Hangzhou 119
Boston 118
Woodbridge 96
Fremont 92
Verona 84
Redwood City 67
Dong Ket 61
Boardman 59
Seattle 55
Lachine 51
Cambridge 45
Pisa 44
Torino 43
Norwalk 39
Falls Church 36
Hefei 30
Munich 30
Menlo Park 26
Guangzhou 25
Brno 23
Shanghai 21
Redmond 20
Brussels 18
Kunming 18
Jinan 17
Mountain View 17
Detroit 15
Nanjing 15
Shenyang 15
Tokyo 15
Los Angeles 14
New York 14
San Diego 14
Taipei 14
Auburn Hills 13
Chicago 12
Chengdu 11
Düsseldorf 11
Monash 11
Hanoi 10
Phoenix 10
Pune 10
Washington 10
Zhengzhou 10
Bologna 9
Turin 9
Columbus 8
Helsinki 8
Philadelphia 8
Rome 8
Nanchang 7
Nürnberg 7
Seoul 7
Spokane 7
Austin 6
Fuzhou 6
Istanbul 6
Sydney 6
Brescia 5
Cairo 5
Hebei 5
Paris 5
Shenzhen 5
Taizhou 5
Arese 4
Bari 4
Bottanuco 4
Campobasso 4
Des Moines 4
Genoa 4
Gent 4
Guadalupe 4
Hyderabad 4
London 4
Naples 4
Rivoli 4
Rotterdam 4
Taormina 4
Tappahannock 4
Vancouver 4
Varese 4
Totale 8.290
Salva come PNG Salva come JPEG
Nome #
Randomized phase II trial of letrozole and letrozole plus low-dose metronomic oral cyclophosphamide as primary systemic treatment in elderly breast cancer patients 539
Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy. 461
Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease 218
Pharmacoeconomic comparison between chronochemotherapy and FOLFOX regimen in the treatment of patients with metastatic colorectal cancer: a cost-minimization study 173
Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen 171
Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis 168
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. 163
Bevacizumab Plus Octreotide and Metronomic Capecitabine in Patients with Metastatic Well-to-Moderately Differentiated Neuroendocrine Tumors. The XELBEVOCT Multicenter Phase II Study 154
[Antiprolactin therapy in the treatment of benign lesions of the breast. Comparison of bromocryptine and methergoline] 152
Thyroid hormone levels in human breast cyst fluid. 144
CIRCADIAN RHYTHM OF BONE TURNOVER MARKERS INBREAST CANCER PATIENTS WITH METASTATIC BONE DISEASE ANDIN CONTROL SUBJECTS 142
Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers 141
Prevalence of complementary/alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features. 135
Adenohypophyseal hormone levels in the cerebrospinal fluid of patients with pituitary disease. 123
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013) 120
Prolactin and thyrotropin response to thyrotropin-releasing hormone in premenopausal women with fibrocystic disease of the breast. 119
Changes of bone turnover markers and serum PTH after night or morning administration of zoledronic acid in breast cancer patients with bone metastases. 119
THE ROLE OF HEMOGLOBIN LEVEL IN PREDICTING THE RESPONSE TO FIRST-LINE CHEMOTHERAPY IN ADVANCED COLORECTAL CANCER (ACC) PATIENTS 118
Stage IB malignant thymoma in a Lynch syndrome patient with multiple cancers: response to incidental administration of oxaliplatin and 5-fluorouracil 114
Cations and dehydroepiandrosterone-sulfate in cyst fluid of pre- and menopausal patients with gross cystic disease of the breast. Evidence for the existence of subpopulations of cysts. 112
Confronto tra due metodi per la misura della concentrazione della cromogranina A circolante in pazienti con iperplasia prostatica benigna e adenocarcinoma prostatico 105
Diagnostica per immagini 100
Chromogranine A serum levels in patients affected by prostate cancer and benign prostate hypertrophy: comparison between two different commercial kits 100
Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer 99
A randomized comparison of high dose epirubicin versus high dose epirubicin plus lonidamine in advanced breast cancer patients. First results from a cooperative group study 96
Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma. 94
Apocrine cells in breast cyst fluid and their relationship to cyst type: a morphometric study. 94
Case-control study of the impact of adjuvant hormone therapy in prostate cancer patients on quality of life, anxiety and depression and self body image perception 94
[Cytostatic therapy of metastatic breast cancer] 93
Circadian rhythm of breakthrough cancer pain. 93
Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial. 92
Melatonin and human cancer. 91
Cronochemioterapia dei tumori del colon-retto avanzati 90
Current status of hormonal therapy of fibrocystic breast disease. 89
Distúrbio Pós-Traumático de Stress, qualidade do sono, ansiedade, depressão e qualidade de vida em pacientes oncológicos em tratamento quimioterápico 85
Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach. 84
Acute myeloblastic leukemia associated with mediastinal nonseminomatous germ cell tumors. Report on two cases. 83
Comparison between two commercially available chromogranin A assays in detecting neuroendocrine differentiation in prostate cancer and benign prostate hyperplasia 82
The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients 82
The transition from pediatrics to adult medicine in patients recovered after an infantile neoplasm 81
Shifted distribution of cation-related cyst types in post-menopausal patients with gross cystic disease of the breast. 80
Aggiornamenti in Cronochemioterapia 80
Prevention of nausea and vomiting in cisplatin-treated patients by a selective 5-hydroxytryptamine (5-HT3) receptor antagonist, ICS 205-930. 79
Biochemical picture of bone metabolism in breast cancer patients with bone metastases. 78
Potential clinical value of circulating chromogranin A in patients with prostate carcinoma. 77
Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy 77
Bisogni di cure palliative: i problemi dei pazienti con tumore nei loro ultimi mesi di vita. Un asurvey in 6 ASL piemontesi 76
Differences between temporal patterns of plasma cortisol and corticosteroid-binding globulin binding capacity throughtout the twenty-four hour day and the menstrual cycle. 75
Cohort study of association of risk of breast cancer with cyst type in women with gross cystic disease of the breast. 75
[Acute effect of ACTH administered in vivo on the 11-beta-hydroxylase activity of rat adrenal gland homogenates] 74
[Study of the distribution and metabolism of T4-I 125 and of T3-I 125 in the rat] 74
Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension. 74
Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma 74
Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease. 73
[On the pituitary-inhibiting action and pharmacokinetics of some synthetic corticosteroids] 73
Changes in body composition after androgen deprivation therapy (ADT) in prostate cancer patients. Relationship with disease outcome 72
Background to and management of treatment-related bone loss in prostate cancer. 71
[Effect of 17-beta-estradiol on inhibition of corticosteroidogenesis obtained with metopirone] 70
[Rapid determination of total estrogens in pregnancy. Possibilities and limitations of the method] 70
Biochemistry of breast cyst fluid. An approach to understanding intercellular communication in the terminal duct lobular units. 69
Influence of neoadjuvant chemotherapy on serum tumor markers CA 15-3, MCA, CEA, TPS and TPA in breast cancer patients with operable disease. 69
The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor load. 69
Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a. A study by the Italian Trials in Medical Oncology Group. 68
THE ONSET OF SKELETAL COMPLICATIONS IN HORMONEREFRACTORY PROSTATE CANCER PATIENTS IS NOT INFLUENCEDBY THE DURATION OF ANDROGEN DEPRIVATION THERAPY 68
[Regional hemodynamics in the rat: changes induced by administration of adrenaline and of a beta-blocking drug (INPEA)] 68
Emerging drugs for adrenocortical carcinoma 67
Chemotherapy with dacarbazine and 5-fluorouracil in advanced medullary thyroid cancer. 67
Risk of depressive events in long-term surviving patients affected by hormone-related cancer according to time after diagnosis 67
Cytotoxic chemotherapy for adrenocortical carcinoma. 67
Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse. 67
A new magnesium-containing PEG-electrolyte solution for the oral lavage of the colon. 66
Advanced prostate cancer: at last a role for medical oncologists 66
A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma. International Organization for Cancer Chronotherapy. 66
Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy 66
[Influence of adrenaline and a beta-blocking drug on distribution of thyroxine] 66
[Influence of a beta-blocking drug on the clearance time of thyroxine-I-125 from plasma in rats] 65
Association of cyst type with risk factors for breast cancer and relapse rate in women with gross cystic disease of the breast. 65
INCREASED NUMBER OF NEUROENDOCRINE CELLS IN METASTATIC COLORECTAL ADENOCARCINOMA FOLLOWING CHEMO/RADIOTHERAPY 65
[Comparison between regional hemodynamics in the rat during barbiturate anesthesia and during ether anesthesia] 64
Circadian rhythm of bone turnover markers in breast cancer patients with bone metastases and in control subjects 64
[Endocrine therapy in breast carcinoma] 63
Somatostatin receptors: from basic science to clinical approach. Unlabeled somatostatin analogues-1: Prostate cancer 63
LONG-TERM SURVIVAL OF PATIENTS WITH RESECTION OF PULMONARY METASTASES FROM COLORECTAL NEOPLASMS AS COMPARED TO NOT RESECTED ONES. A RETROSPECTIVE STUDY ON PATIENTS FOLLOWED FROM THE TIME OF FIRST RECURRENCE 63
The role of hemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer (ACC) 63
[Preliminary observations on the influence of thyroxine on the 11-beta-hydroxylase activity of homogenized extracts of rat adrenal glands in vitro] 62
Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer 62
Six-year stabilisation of a relapsed pelvic mass from rectal cancer after oxaliplatin-containing chemotherapy 62
Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly 62
Il trattamento dell'ascite neoplastica: obiettivi e criteri di valutazione 62
Durable complete remission after weekly docetaxel administration in a patient with mediastinal non-seminomatous germ-cell tumor refractory to cisplatin-based chemotherapy 62
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC). 61
Laparoscopic treatment of Morgagni-Larrey hernia: technical details and report of a series 60
Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients. 60
[Therapeutic use of corticosteroids] 60
The neuroendocrine phenotype in prostate cancer: basic and clinical aspects 60
Osteoblastic flare assessed by serum alkaline phosphatase activity is an index of short duration of response in prostate cancer patients with bone metastases submitted to systemic therapy.Gruppo Onco Urologico Piemontese (G.O.U.P). 60
Adjuvant sequential methotrexate --> 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer 60
Low-dose spiral CT for early diagnosis of lung cancer in a light risk population: 2-year results 60
Cronochemioterapia dei tumori del colon retto metastatici 59
Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review. 59
Totale 9.457
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.817
article - articoli 0
book - libri 0
conference - conferenze 4.275
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.092
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.281 64 86 183 202 233 476 321 139 223 130 153 71
2020/20211.538 179 44 188 80 133 63 175 29 233 143 75 196
2021/20221.972 27 67 70 317 122 59 233 80 53 84 309 551
2022/20232.488 336 178 43 215 224 738 214 139 239 23 85 54
2023/2024971 137 183 62 56 31 68 7 35 13 70 117 192
2024/202548 48 0 0 0 0 0 0 0 0 0 0 0
Totale 15.007